- Home
- Advocacy
- Latest News and Practice Data
- Louisiana bill to rename cytotechnologists fails in committee
On May 20, Louisiana House Bill 1216 failed to advance out of the state Senate Health and Welfare Committee, halting a proposal to rename “cytotechnologists” as “cytologists.”
The bill, introduced on behalf of the Louisiana State Board of Medical Examiners, aimed to update the state’s clinical laboratory licensure law and align terminology with a national credentialing organization.
The impact: The bill’s failure preserves existing terminology that clearly distinguishes cytotechnologists from pathologists under federal law.
- Under CLIA regulations (42 CFR 493.1483), “cytotechnologist” is a defined role separate from the practice of medicine by pathologists.
- Changing the title could have created confusion for patients and the public and introduced legal and regulatory uncertainty.
- No other state recognizes “cytologist” in licensure laws; those with laboratory personnel licensure refer to “cytotechnologist.”
What we’re saying: In an opposition letter, the CAP and the Louisiana Pathology Society warned that departing from established terminology could create compliance challenges and undermine clarity in laboratory roles.
- The Louisiana State Medical Society supported our position.
What’s next: The CAP will monitor for any effort to reintroduce similar legislation in Louisiana.